OMB Individually Reported

Resource Capacity Planning

Low riskExact public inventory row

Description

FDA needs to accurately predict the volume and complexity of incoming drug application submissions to ensure appropriate staffing and resources are available for timely reviews under the user fee program

Detailed example

Forecasts workload submissions across major user fee programs to help support fee setting for the human drug review programs

AI / analytics pattern

Classical/Predictive Machine Learning: Models trained on data to make predictions or classifications based on identified patterns or relationships.

Automation level / stage

c) Deployed – The use case is being actively authorized or utilized to support the functions or mission of an agency.

Expected benefit

Forecasting human drug review program submissions and corresponding FDA workload to support better resource planning and ensure timely review of drug applications that benefit public health.

Controls / human review

ATO: Yes; PIA: Not published

Data needed

FDA systems including DARRTS and Panorama